COVID-19 prevention and control effect of non-pharmaceutical interventions-fuzzy-sets qualitative comparative analysis based on 69 countries in the world.

Journal: Frontiers in public health
PMID:

Abstract

INTRODUCTION: Coronavirus disease 2019 occurred unexpectedly in late December 2019, it was difficult to immediately develop an effective vaccine or propose targeted medical interventions in the early stages of the outbreak. At this point, non-pharmaceutical interventions (NPIs) are essential components of the public health response to COVID-19. How to combine different NPIs in the early stages of an outbreak to control the spread of epidemics and ensure that the policy combination does not incur high socio-economic costs became the focus of this study.

Authors

  • Chunxiao Yang
    School of Public Health, Shandong Second Medical University, Weifang, Shandong, China.
  • Qiusha Li
    School of Public Health, Shandong Second Medical University, Weifang, Shandong, China.
  • Zixuan Zhao
    School of Public Health, Shandong Second Medical University, Weifang, Shandong, China.
  • Zhongming Chen
    LifeBridge Health, Sinai Hospital of Baltimore, Rubin Institute for Advanced Orthopedics, Baltimore, Maryland.
  • Hongwei Guo
    School of Management, Shandong Second Medical University, Weifang, Shandong, China.
  • Dongmei Huang
    School of Management, Shandong Second Medical University, Weifang, Shandong, China.
  • Wenqiang Yin
    School of Management, Shandong Second Medical University, Weifang, Shandong, China.